Home > Technology > Celerent to Provide Implementation Services to Celera Genomics

Celerent to Provide Implementation Services to Celera Genomics

Added: (Tue Oct 31 2000)

Pressbox (Press Release) - MANCHESTER, NH, October 30, 2000 - Celerent, Inc. is pleased to announce that
they have been awarded follow-on contracts for project management, technical
consulting and implementation services from Celera Genomics (NYSE: CRA),
a PE Corporation business.

This award follows initial contracts between the two companies for technical consulting
and implementation services delivered earlier this year.

Previously, Celerent assisted Celera's technical team in implementing numerous
computing projects including their archiving and database systems.
Celerent reconfigured and consolidated Celera's systems resulting in better utilization
and performance.


In the follow-on contract, Celerent will continue to supply technical consulting and
implementation services, and will also include project management to assist with
scaling of existing servers and an operating system upgrade rollout for hundreds of
Celera's systems.


"By outsourcing some of their implementation and project management to Celerent,
Celera is able to concentrate on their core business. Knowing that our efforts
contribute towards Celera's goals inspires us to do more, faster," said Tony Dancona,
Celerent's president and chief executive officer. "We congratulate Celera on achieving
their historic goal of decoding the human genome and look forward to helping as they
embark on their next journey to new discoveries that will benefit mankind."

"Celerent has ensured that our systems are built to high standards and are well
documented, tested and mission-ready," said Marshall Peterson, Celera Genomics'
vice-president of Infrastructure Technology. "Celera computational requirements
demand high availability and high performance. Celerent has contributed significantly
to Celera's ability to meet aggressive computational challenges."

On June 26, 2000, Celera announced that it had completed the first assembly of the
human genome. An assembled genome is one where the location and order of the
letters of genetic code along the chromosomes are known. The calculation to
perform the assembly involved 500 million trillion base to base comparisons requiring
over 20,000 CPU (central processor unit) hours on Celera's supercomputer.

Celera's computing partner is Compaq Computer Corporation (NYSE: CPQ). In
completing the sequencing and assembly of the 3.12 billion letters of genetic code,
Celera relied exclusively on networked Compaq AlphaServer computers running Tru64
UNIX and TruCluster software to manage the more than 80 terabytes of data and to
perform what are believed to be some of the most complex computations in the
history of commercial supercomputing.

PE Corporation comprises two operating groups. The Celera Genomics Group,
headquartered in Rockville, MD, intends to become the definitive source of genomic
and related medical information. The PE Biosystems Group (NYSE: PEB),
headquartered in Foster City, CA and with sales of $1.2 billion during fiscal 1999,
develops and markets instrument-based systems, reagents, software, and contract
related services to the life science industry and research community. Information
about the company, including reports and other information filed by the company
with the Securities and Exchange Commission, is available on the World Wide Web
at http://www.pecorporation.com or by phoning (800) 762-6923.

Celerent, Inc. is a computer/network consulting and implementation services
company headquartered in Manchester, NH. Information about the company is
available on the World Wide Web at http://www.celerent.com or contact Gary Hicks
at (603) 647-0857 ext. 205.
Copyright (c) 2000. Celerent, Inc. All Rights Reserved.
Celera, Celera Genomics, and PE Biosystems are trademarks of PE Corporation.

Submitted by:
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.